Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | MMP1 | Interstitial collagenase | P03956 | CLG | rs2 | CRYSTAL STRUCTURE OF FIBROBLAST COLLAGENASE-1 COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID | 966c | 79.21 | | 23. |
2 | MMP10 | Stromelysin-2 | P09238 | STMY2 | ngh | Crystal structure of the catalytic domain of human matrix metalloproteinase 10 | 1q3a | 84.91 | | no data |
3 | MMP12 | Macrophage metalloelastase | P39900 | HME | hs5 | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor 4-fluoro-N-(2-hydroxyethyl)-N-(2-nitroso-2-oxoethyl)benzenesulfonamide | 3f18 | 77 | | 39.5 |
4 | MMP12 | Macrophage metalloelastase | P39900 | HME | deo | Crystal structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid | 1ros | 81.17 | | 1.7 |
5 | MMP12 | Macrophage metalloelastase | P39900 | HME | b9z | Crystal structure of MMP12 in complex with inhibitor BE4. | 6ela | 79.82 | | no data |
6 | MMP12 | Macrophage metalloelastase | P39900 | HME | b9n | Crystal structure of MMP12 in complex with inhibitor BE7. | 6ekn | 76.66 | | no data |
7 | MMP12 | Macrophage metalloelastase | P39900 | HME | cp8 | Crystal Structure of MMP-12 complexed to 2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4-yl)-4-oxobutanoic acid | 1utt | 81.81 | | 100000. |
8 | MMP12 | Macrophage metalloelastase | P39900 | HME | 576 | MMP12 complex with a beta hydroxy carboxylic acid | 2woa | 90 | | 1150. |
9 | MMP12 | Macrophage metalloelastase | P39900 | HME | cgs | Crystal Structure Analysis of human Macrophage Elastase MMP-12 | 1jiz | 66.42 | | 2. |
10 | MMP12 | Macrophage metalloelastase | P39900 | HME | cgs | Does a Fast Nuclear Magnetic Resonance Spectroscopy- and X-Ray Crystallography Hybrid Approach Provide Reliable Structural Information of Ligand-Protein Complexes? A Case Study of Metalloproteinases. | 2w0d | 84.5 | | 2. |
11 | MMP12 | Macrophage metalloelastase | P39900 | HME | jt5 | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-hydroxy-2-(N-hydroxyethyl)biphenyl-4-ylsulfonamido)acetamide | 3n2v | 79.07 | | 31. |
12 | MMP12 | Macrophage metalloelastase | P39900 | HME | nhk | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor N-Hydroxy-2-(N-(2-hydroxyethyl)4-methoxyphenylsulfonamido)acetamide | 3nx7 | 78.7 | | 7.88 |
13 | MMP12 | Macrophage metalloelastase | P39900 | HME | z79 | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor paramethoxy-sulfonyl-glycine hydroxamate | 3lk8 | 87.26 | | 19.7 |
14 | MMP12 | Macrophage metalloelastase | P39900 | HME | 0d2 | MMP12 in a complex with the dimeric adduct: 5-(5-phenylhydantoin)-5-phenylhydantoin | 3uvc | 97.07 | | no data |
15 | MMP12 | Macrophage metalloelastase | P39900 | HME | ngh | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH | 5lab | 76.02 | | no data |
16 | MMP12 | Macrophage metalloelastase | P39900 | HME | ngh | Crystal structure of the catalytic domain of human MMP12 complexed with the inhibitor NNGH at 1.3 A resolution | 1rmz | 76.11 | | 10. |
17 | MMP12 | Macrophage metalloelastase | P39900 | HME | e37 | Human MMP12 in complex with L-glutamate motif inhibitor | 4efs | 91.34 | | 2.5 |
18 | MMP12 | Macrophage metalloelastase | P39900 | HME | 10b | Crystal structure of the catalytic domain of Human MMP12 in complex with a broad spectrum hydroxamate inhibitor | 4h76 | 77.7 | | no data |
19 | MMP12 | Macrophage metalloelastase | P39900 | HME | y38 | Crystal structure of the catalytic domain of Human MMP12 in complex with a selective carboxylate based inhibitor. | 4h84 | 95.62 | | no data |
20 | MMP12 | Macrophage metalloelastase | P39900 | HME | lpw | Crystal structure of MMP12 in complex with hydroxamate inhibitor LP168. | 6enm | 79.61 | | no data |
21 | MMP13 | Collagenase 3 | P45452 | | az6 | Mmp13 in complex with a piperazine hydantoin ligand | 4jpa | 77.5 | | 3.3 |
22 | MMP13 | Collagenase 3 | P45452 | | az4 | Mmp13 in complex with a reverse hydroxamate Zn-binder | 4jp4 | 79.78 | | no data |
23 | MMP13 | Collagenase 3 | P45452 | | 8om | Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-10a | 5uwk | 83.14 | | 2.3 |
24 | MMP13 | Collagenase 3 | P45452 | | 518 | MMP-13 in complex with a non zinc-chelating inhibitor | 3i7i | 76.64 | | 620. |
25 | MMP13 | Collagenase 3 | P45452 | | 3kr | Crystal structure of MMP-13 in complex with SC-78080 | 3kry | 73.92 | | 0.1 |
26 | MMP13 | Collagenase 3 | P45452 | | 24f | Crystal Structure of MMP-13 Complexed with Inhibitor 24f | 3elm | 78.87 | | 0.19 |
27 | MMP13 | Collagenase 3 | P45452 | | 033 | Crystal structure of the catalytic domain of MMP-13 complexed with WAY-033 | 1ztq | 77.18 | | 1.3 |
28 | MMP13 | Collagenase 3 | P45452 | | pb3 | Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | 1xuc | 90 | | 72. |
29 | MMP13 | Collagenase 3 | P45452 | | pb4 | Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | 1xud | 90.19 | | 8. |
30 | MMP13 | Collagenase 3 | P45452 | | pb5 | Matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | 1xur | 91.85 | | 6600. |
31 | MMP13 | Collagenase 3 | P45452 | | pfd | Crystal structure of the catalytic domain of MMP-13 complexed with a potent pyrimidinetrione inhibitor | 1you | 76.97 | | 0.87 |
32 | MMP13 | Collagenase 3 | P45452 | | gg1 | MMP13 Catalytic Domain Complexed with 4-{[1-methyl-2,4-dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin-3(2H)-yl]methyl}benzoic acid | 2ozr | 91.53 | | 0.67 |
33 | MMP13 | Collagenase 3 | P45452 | | 347 | Crystal structure of the catalytic domain of MMP-13 complexed with WAY-344 | 2pjt | 65.66 | | 860. |
34 | MMP13 | Collagenase 3 | P45452 | | 5el | MMP13 in complex with a novel selective non zinc binding inhibitor | 2yig | 75.66 | | 79.4 |
35 | MMP13 | Collagenase 3 | P45452 | | 732 | MMP-13 in complex with a non zinc-chelating inhibitor | 3i7g | 75.04 | | 430. |
36 | MMP13 | Collagenase 3 | P45452 | | 3ke | Crystal Structure of Human MMP-13 complexed with a phenyl-2H-tetrazole compound | 3kec | 90.86 | | 58. |
37 | MMP13 | Collagenase 3 | P45452 | | 3ej | Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound | 3kej | 89.83 | | 75.9 |
38 | MMP13 | Collagenase 3 | P45452 | | 3ek | Crystal Structure of Human MMP-13 complexed with a (pyridin-4-yl)-2H-tetrazole compound | 3kek | 89.49 | | 4.4 |
39 | MMP13 | Collagenase 3 | P45452 | | la3 | Crystal Structure of Human MMP-13 complexed with an Amino-2-indanol compound | 3ljz | 76.33 | | 7.3 |
40 | MMP13 | Collagenase 3 | P45452 | | whh | Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxybenzyl)carbamoyl)-4-oxo-3,4-dihydroquinazolin-5-yl)oxy)ethyl)benzoic acid | 3wv1 | 92.27 | | 0.0039 |
41 | MMP13 | Collagenase 3 | P45452 | | wgg | Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydroquinazoline-2-carboxamide | 3wv2 | 89.26 | | 12. |
42 | MMP13 | Collagenase 3 | P45452 | | wll | Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-2-carboxamide | 3wv3 | 86.71 | | 24. |
43 | MMP13 | Collagenase 3 | P45452 | | e41 | MMP-13 complexed with 2-Napthylsulfonamide hydroxamic acid inhibitor | 3zxh | 69.37 | | 3. |
44 | MMP13 | Collagenase 3 | P45452 | | cbp | STRUCTURE OF RECOMBINANT MOUSE COLLAGENASE-3 (MMP-13) | 1cxv | 80.77 | | no data |
45 | MMP13 | Collagenase 3 | P45452 | | cbp | CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID | 456c | 77.95 | | 0.17 |
46 | MMP13 | Collagenase 3 | P45452 | | 3w4 | MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22 | 4a7b | 75.78 | | no data |
47 | MMP13 | Collagenase 3 | P45452 | | 3w5 | MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22 | 4a7b | 74.85 | | 39.8 |
48 | MMP13 | Collagenase 3 | P45452 | | wnn | Crystal structure of the catalytic domain of MMP-13 complexed with 4-oxo-N-(3-(2-(1H-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4-dihydroquinazoline-2-carboxamide | 5b5p | 83.05 | | 0.2 |
49 | MMP13 | Collagenase 3 | P45452 | | 4uf | X-RAY Co-structure of MMP-13 with 4-[({5-[2-(ethoxycarbonyl)-1H-indol-5-yl]-1-methyl-1H-pyrazol-3-yl}formamido)methyl]benzoate | 5bpa | 87.87 | | 1. |
50 | MMP13 | Collagenase 3 | P45452 | | 8oj | Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-17a | 5uwl | 85.67 | | 9.4 |
51 | MMP13 | Collagenase 3 | P45452 | | rs1 | COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID | 830c | 79.19 | | 0.52 |
52 | MMP3 | Stromelysin-1 | P08254 | STMY1 | spc | CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR. | 1d7x | 87.97 | | 3. |
53 | MMP3 | Stromelysin-1 | P08254 | STMY1 | n25 | DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS | 1bqo | 71.95 | | 18.4 |
54 | MMP3 | Stromelysin-1 | P08254 | STMY1 | in7 | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY | 1b8y | 88.3 | | 14. |
55 | MMP3 | Stromelysin-1 | P08254 | STMY1 | s80 | DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS | 1biw | 65.69 | | 104. |
56 | MMP3 | Stromelysin-1 | P08254 | STMY1 | mm3 | CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A THIAZEPINE BASED INHIBITOR. | 1d5j | 76.72 | | 0.7 |
57 | MMP3 | Stromelysin-1 | P08254 | STMY1 | hqq | X-ray Structure of a Novel Matrix Metalloproteinase Inhibitor Complexed to Stromelysin | 1g4k | 87.21 | | 2000. |
58 | MMP3 | Stromelysin-1 | P08254 | STMY1 | in9 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372 | 1usn | 61.35 | | 18. |
59 | MMP3 | Stromelysin-1 | P08254 | STMY1 | ohl | catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methoxy-N-(pyridine-3-ylmethyl)phenylsulfonamido)acetamide | 3ohl | 73.32 | | no data |
60 | MMP3 | Stromelysin-1 | P08254 | STMY1 | z79 | catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methylphenylsulfonamido)acetamide | 3oho | 85.51 | | no data |
61 | MMP7 | Matrilysin | P09237 | MPSL1 PUMP1 | tqj | The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger | 2y6d | 72.49 | | 79. |
62 | MMP7 | Matrilysin | P09237 | MPSL1 PUMP1 | rss | MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR | 1mmp | 64.76 | | 850. |
63 | MMP7 | Matrilysin | P09237 | MPSL1 PUMP1 | rrs | MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR | 1mmq | 65.11 | | 30. |
64 | MMP7 | Matrilysin | P09237 | MPSL1 PUMP1 | srs | MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR | 1mmr | 64.49 | | 4000. |
65 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | axb | Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor | 3dpf | 85.71 | | 57. |
66 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | axb | Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor | 3dpe | 85.72 | | 57. |
67 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | bsi | CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909 | 1bzs | 76.55 | | 10. |
68 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | bsi | COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) | 1i76 | 76.9 | | no data |
69 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | bbt | Crystal Structure of MMP8-Barbiturate Complex Reveals Mechanism for Collagen Substrate Recognition | 1jj9 | 70.46 | | 1700. |
70 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | 2ni | Crystal structure of the complex between MMP-8 and a N-hydroxyurea inhibitor | 1zp5 | 80.7 | | 1.2e+006 |
71 | MMP8 | Neutrophil collagenase | P22894 | CLG1 | axa | Crystal structure of the complex between MMP-8 and a non-zinc chelating inhibitor | 3dng | 92.01 | | 7.4 |
72 | MMP9 | Matrix metalloproteinase-9 | P14780 | CLG4B | 10b | Crystal structure of an MMP broad spectrum hydroxamate based inhibitor CC27 in complex with the MMP-9 catalytic domain | 4h3x | 92.01 | | no data |
73 | MMP9 | Matrix metalloproteinase-9 | P14780 | CLG4B | e40 | Crystal structure of a hydroxamate based inhibitor EN140 in complex with the MMP-9 catalytic domain | 4wzv | 87.09 | | 0.43 |
74 | MMP9 | Matrix metalloproteinase-9 | P14780 | CLG4B | b9z | Crystal structure of MMP9 in complex with inhibitor BE4. | 6esm | 82.13 | | no data |